- 4-Week # shares sold: 5,000
- 12-Week # shares bought: 2,000
- 12-Week # shares sold: 5,000
- 24-Week # shares bought: 2,000
- 24-Week # shares sold: 10,000
The company has spent $600 million weighing a potential breakup.
Hedge fund billionaire Dan Loeb owns a greater than 17% stake in the newly public developer of a drugs including those for treatment of psoriasis.